Pancreatic Cancer Research

ResearcherKobe UniversityActive in the last 2 years

Mika Miki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-3276-0510; OpenAlex author ID A5000854334. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2023: 3 papers · 2024: 3 papers · 2025: none · 2026: 2 papers

Papers 8

  1. Biological Borderline Resectable Pancreatic Cancer Represents a Genetically and Immunologically Aggressive Subtype: A Retrospective Study. Co-author DOI 10.1097/sla.0000000000007075↗
  2. Deep Learning Detection of Direct and Indirect Imaging Findings Associated with Pancreatic Cancer at Contrast-enhanced and Noncontrast CT. Co-author DOI 10.1148/radiol.253122↗
  3. Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00535-023-02069-5↗
  4. Association of pancreatic atrophy patterns with intraductal extension of early pancreatic ductal adenocarcinoma: a multicenter retrospective study. Co-author DOI 10.1007/s00535-024-02149-0↗
  5. Treatment and Prognosis for Pancreatic Duct Disruption Associated With Pancreatic Cancer: A Case Series of 15 Patients. Co-author DOI 10.7759/cureus.67482↗
  6. A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal… Co-author DOI 10.1007/s00535-023-02020-8↗
  7. Benefits of pancreatic parenchymal endoscopic ultrasonography in predicting microscopic precancerous lesions of pancreatic cancer. Co-author DOI 10.1038/s41598-023-38920-1↗
  8. Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Anal… Co-author DOI 10.1245/s10434-023-13569-2↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Atsuhiro Masuda · 8 shared papers, 2023–2026 · strength 1.26
  2. Arata Sakai · 8 shared papers, 2023–2026 · strength 1.26
  3. Masanori Gonda · 7 shared papers, 2023–2026 · strength 1.10
  4. Masahiro Tsujimae · 7 shared papers, 2023–2026 · strength 1.06
  5. Takashi Kobayashi · 7 shared papers, 2023–2026 · strength 1.05
  6. Keitaro Sofue · 6 shared papers, 2023–2026 · strength 0.95
  7. Yoshiyuki Harada · 6 shared papers, 2023–2026 · strength 0.90
  8. Takumi Fukumoto · 6 shared papers, 2023–2026 · strength 0.90
  9. Hirochika Toyama · 6 shared papers, 2023–2024 · strength 0.86
  10. Yuzo Kodama · 6 shared papers, 2023–2024 · strength 0.86
  11. Takeshi Tanaka · 5 shared papers, 2023–2024 · strength 0.70
  12. Tomoo Itoh · 5 shared papers, 2023–2024 · strength 0.69
  13. Shigeto Ashina · 4 shared papers, 2023–2026 · strength 0.58
  14. Shigeto Masuda · 4 shared papers, 2023–2024 · strength 0.53
  15. Kohei Yamakawa · 4 shared papers, 2023–2024 · strength 0.53
  16. Shohei Abe · 4 shared papers, 2023–2024 · strength 0.53
  17. Yoshihide Nanno · 2 shared papers, 2023–2026 · strength 0.33
  18. Yuki Oka · 2 shared papers, 2024 · strength 0.31
  19. Mamoru Takenaka · 2 shared papers, 2023–2024 · strength 0.29
  20. Takayuki Kodama · 1 shared paper, 2026 · strength 0.20
  21. Yuzo Kodama · 1 shared paper, 2026 · strength 0.20
  22. Yu Arai · 1 shared paper, 2026 · strength 0.20
  23. Takamichi Murakami · 1 shared paper, 2026 · strength 0.20
  24. Takeru Yamaguchi · 1 shared paper, 2026 · strength 0.20
  25. Takuya Ikegawa · 1 shared paper, 2026 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.